Frank Rigo
49Patents
9h-index
46Co-inventors
71Inventor score
Filing activity: Jun 17, 2010 → Jun 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8980853B2 | Compositions and methods for modulation of SMN2 splicing in a subject | Chemistry; Metallurgy | 30 | Active |
| US9717750B2 | Compositions and methods for modulation of SMN2 splicing in a subject | Chemistry; Metallurgy | 19 | Active |
| US9518259B2 | Compounds and methods for modulating interaction between proteins and target nucleic acids | Chemistry; Metallurgy | 18 | Active |
| US10538763B2 | Compounds and methods for modulation of DUX4 | Chemistry; Metallurgy | 18 | Active |
| US9605263B2 | Compositions for modulating C9ORF72 expression | Chemistry; Metallurgy | 17 | Active |
| US9963699B2 | Methods for modulating C9ORF72 expression | Chemistry; Metallurgy | 15 | Active |
| US9926559B2 | Compositions and methods for modulation of SMN2 splicing in a subject | Chemistry; Metallurgy | 10 | Active |
| US9617539B2 | Modulation of UBE3A-ATS expression | Chemistry; Metallurgy | 10 | Active |
| US10138482B2 | Compositions for modulating C9ORF72 expression | Chemistry; Metallurgy | 9 | Active |
| US9644207B2 | Compositions and methods for modulating Tau expression | Chemistry; Metallurgy | 9 | Active |
| US10436802B2 | Methods for treating spinal muscular atrophy | Physics | 9 | Active |
| US10221414B2 | Compositions for modulating C9ORF72 expression | Chemistry; Metallurgy | 9 | Active |
| US10273474B2 | Methods for modulating Tau expression for reducing seizure and modifying a neurodegenerative syndrome | Chemistry; Metallurgy | 3 | Active |
| US10407678B2 | Compositions for modulating expression of C9ORF72 antisense transcript | Chemistry; Metallurgy | 3 | Active |
| US10533175B2 | Compositions and methods for modulating Ataxin 3 expression | Chemistry; Metallurgy | 3 | Active |
| US11058709B1 | Methods of treating breast cancer | Chemistry; Metallurgy | 2 | Active |
| US10815483B2 | Compositions for modulating C9ORF72 expression | Chemistry; Metallurgy | 2 | Active |
| US10400243B2 | Modulation of UBE3A-ATS expression | Chemistry; Metallurgy | 2 | Active |
| US11033570B2 | Modulation of Lnc05 expression | Chemistry; Metallurgy | 2 | Active |
| US11732260B2 | Compounds and methods for the modulation of amyloid-β precursor protein | Chemistry; Metallurgy | 1 | Active |
| US11299737B1 | Compounds and methods for modulating SMN2 | Chemistry; Metallurgy | 1 | Active |
| US11725208B2 | Conjugated antisense compounds and their use | Chemistry; Metallurgy | 1 | Active |
| US11781135B2 | Methods for treating Alzheimer's disease | Chemistry; Metallurgy | 1 | Active |
| US9353371B2 | Antisense compounds targeting genes associated with usher syndrome | Chemistry; Metallurgy | 1 | Active |
| US10793855B2 | Compositions for modulating expression of C9ORF72 antisense transcript | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.